Labviva, Inc. — Form D
Labviva, Inc. of SOMERVILLE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-17. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-06-17
- Form: D
- Accession: 0001775363-21-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Investors: 3
- Date of first sale: 2021-06-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-403206
Issuer
- Name: Labviva, Inc.
- CIK: 0001775363
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 212 ELM STREET, 4TH FLOOR, SOMERVILLE, MA, 02144
- Phone: 800-8321280
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Siamak Baharloo | Director | Somerville, MA |
| Sarah Fay | Director | Somerville, MA |
| Evan Lodes | Director | Cambridge, MA |
| Nicholas Rioux | Director | Somerville, MA |
| Siamak Baharloo | Executive Officer | Somerville, MA |
| Aaron Miramontes | Executive Officer | Somerville, MA |
| Nicholas Rioux | Executive Officer | Somerville, MA |
| Sarah Fay | Related Person | Somerville, MA |
| Nicholas Rioux | Related Person | Somerville, MA |
| Siamak Baharloo | Related Person | Somerville, MA |
| Aaron Miramontes | Related Person | Somerville, MA |
Other filings by this issuer (1)
More